Tag: Gufic Biosciences
Gufic Biosciences gets TGA, ANVISA nod for Parecoxib Sodium
Gufic Biosciences Limited (Gufic) has received regulatory approval from the Therapeutic Group Administration (TGA) in Australia and the National Health Surveillance Agency (ANVISA) in Brazil ... Read More
Gufic Biosciences secures NMPA approval to market Prilocaine (API) in China
Gufic Biosciences has received approval from the National Medical Products Administration (NMPA) in China for its product, Prilocaine (API), an amide-type local anesthetic. The approval ... Read More
Gufic Biosciences gets DCGI nod for Thymosin Alpha-1 in Covid-19
Gufic Biosciences has secured approval from the Drugs Controller General of India (DCGI) for Thymosin Alpha-1 (Immunocin α) as an add-on therapy for the treatment ... Read More